Altamira Therapeutics Ltd.
CYTOF
$0.07
$0.009916.47%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 65.50K | 65.50K | 733.20K | 675.10K | 55.40K |
| Total Receivables | 121.30K | 121.30K | 88.90K | 81.80K | 880.60K |
| Inventory | -- | -- | -- | -- | 302.30K |
| Prepaid Expenses | 75.20K | 75.20K | 84.60K | 77.90K | 418.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 262.00K | 262.00K | 545.90K | 502.70K | 276.10K |
| Total Current Assets | 524.00K | 524.00K | 1.45M | 1.34M | 1.93M |
|
|
|||||
| Total Current Assets | 524.00K | 524.00K | 1.45M | 1.34M | 1.93M |
| Net Property, Plant & Equipment | 417.60K | 417.60K | 95.10K | 87.60K | 433.30K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 4.63M | 4.63M | 4.62M | 4.26M | 4.35M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 8.07M | 8.07M | 9.14M | 8.41M | 6.93M |
|
|
|||||
| Total Accounts Payable | 526.60K | 526.60K | 490.60K | 451.70K | 2.19M |
| Total Accrued Expenses | 577.90K | 577.90K | 414.30K | 381.50K | 1.29M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 123.40K | 123.40K | 118.40K | 109.00K | 2.51M |
| Total Finance Division Other Current Liabilities | -- | -- | 32.40K | 29.90K | -- |
| Total Other Current Liabilities | -- | -- | 32.40K | 29.90K | -- |
| Total Current Liabilities | 1.23M | 1.23M | 1.06M | 972.00K | 6.00M |
|
|
|||||
| Total Current Liabilities | 1.23M | 1.23M | 1.06M | 972.00K | 6.00M |
| Long-Term Debt | -- | -- | -- | -- | 1.04M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 304.10K | 304.10K | -- | -- | 321.60K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 218.90K | 218.90K | 411.60K | 379.00K | 1.61M |
| Total Liabilities | 1.75M | 1.75M | 1.47M | 1.35M | 8.97M |
|
|
|||||
| Common Stock & APIC | 5.30K | 5.30K | 23.88M | 21.99M | 19.17M |
| Retained Earnings | 1.26M | 1.26M | -21.43M | -19.73M | -22.18M |
| Treasury Stock & Other | 5.05M | 5.05M | 5.22M | 4.81M | 974.00K |
| Total Common Equity | 6.32M | 6.32M | 7.67M | 7.06M | -2.04M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 6.32M | 6.32M | 7.67M | 7.06M | -2.04M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 6.32M | 6.32M | 7.67M | 7.06M | -2.04M |
|
|
|||||
